The BESST study in The Lancet found that brief cognitive behavioral therapy workshops for stress in UK adolescents showed clinical and cost-effectiveness at six months, compared to standard treatment.
Novo Nordisk defends Ozempic’s price in face of Senate scrutiny
Novo Nordisk defended the prices of its blockbuster diabetes and obesity drugs Ozempic and Wegovy amid a Senate probe into what the company charges. Speaking